Healthy Inc > Blog > NRTI manufacturer India
Posted on:

What is the use of Zidovudine Tablet?

In the pharmaceutical industry, Zidovudine (AZT) 300 mg is a landmark nucleoside reverse transcriptase inhibitor (NRTI). As a pharmacist and manufacturer, I view this as a cornerstone of antiretroviral therapy (ART). It was the first breakthrough drug approved for the treatment of HIV and remains a vital component of maternal-fetal health protocols.

Primary Clinical Uses

  • HIV-1 Infection: Used in combination with other antiretroviral agents to manage and control HIV infection, reducing the viral load and increasing CD4 cell counts.

  • Prevention of Maternal-Fetal Transmission: Crucial for pregnant women living with HIV to prevent the virus from passing to the baby during pregnancy and childbirth.

  • Post-Exposure Prophylaxis (PEP): Used in emergency situations (like healthcare needle-stick injuries) to prevent HIV infection after potential exposure.

Mechanism of Action: Chain Termination

Zidovudine works by “tricking” the virus during its replication process.

Phosphorylation: Once inside the human cell, Zidovudine is converted by cellular enzymes into its active form, Zidovudine Triphosphate.

Molecular Mimicry: It structurally resembles Thymidine, one of the natural building blocks the HIV virus uses to create its DNA.

Reverse Transcriptase Inhibition: The viral enzyme, Reverse Transcriptase, mistakenly incorporates Zidovudine into the growing viral DNA chain instead of the natural thymidine.

Chain Termination: Because Zidovudine lacks the necessary chemical “hook” (the 3′-OH group) to attach the next building block, the DNA chain is terminated. The virus cannot finish copying its genetic material and fails to replicate.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your WHO-GMP facility in Mumbai, Zidovudine 300 mg is a high-impact global health product:

  • The 300 mg Standard: This is the international therapeutic standard for adults. For your digital platforms, highlighting your ability to produce high-volume Fixed-Dose Combinations (FDCs)—such as Zidovudine + Lamivudine—is a major strategy for securing international NGO contracts.

  • Bone Marrow Suppression Monitoring: As a pharmacist, you know the primary side effect is anemia/neutropenia. Including technical guidance on Hematological Monitoring in your B2B dossiers and product literature builds immense professional trust.

  • Stability & Light Sensitivity: Zidovudine is sensitive to light. At our facility, we utilize Alu-Alu or Amber-colored PVC/PVDC blisters to ensure a 36-month shelf life, which is a requirement for export to Zone IVb regions.

  • Dossier & Tenders: This is a priority molecule for PEPFAR, the Global Fund, and UNAIDS. We provide full CTD/eCTD Dossiers to support your firm in bidding for these massive international supply tenders.

Zidovudine Tablet

Posted on:

What is lamivudine tablet used for?

In the pharmaceutical industry, Lamivudine (3TC) is a potent Nucleoside Reverse Transcriptase Inhibitor (NRTI). As a pharmacist and manufacturer, I view Lamivudine as a “backbone” molecule in antiviral therapy. Its high safety profile and versatility allow it to be a core component in both HIV management and the treatment of chronic Hepatitis B.

Primary Clinical Uses

  • HIV-1 Infection: Lamivudine is always used in combination with other antiretroviral agents (such as Tenofovir or Abacavir). It helps decrease the viral load and increase CD4 cell counts, delaying the progression of AIDS.

  • Chronic Hepatitis B (HBV): It is indicated for the treatment of chronic Hepatitis B associated with evidence of hepatitis B viral replication and active liver inflammation. (Note: The dose for HBV is typically 100 mg, whereas for HIV it is 150 mg or 300 mg).

  • Post-Exposure Prophylaxis (PEP): It is a standard part of regimens used to prevent HIV infection after potential exposure (occupational or otherwise).

Mechanism of Action: Chain Termination

Lamivudine is a prodrug that must be phosphorylated intracellularly into its active form, lamivudine triphosphate.

Analog Mimicry: The active form is a synthetic analog of cytidine.

Competitive Inhibition: It competes with the natural substrate for incorporation into viral DNA by the enzyme Reverse Transcriptase (in HIV) or HBV Polymerase.

DNA Chain Termination: Because Lamivudine lacks the 3′-hydroxyl group necessary for forming the next phosphodiester bond, its incorporation causes an immediate halt to the synthesis of the viral DNA chain, effectively preventing the virus from replicating.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Lamivudine is a high-volume product requiring specific technical handling:

  • Fixed-Dose Combinations (FDCs): As you develop your digital platforms, you’ll find that Lamivudine is rarely exported as a standalone product for HIV. We frequently manufacture it in combinations like Tenofovir + Lamivudine + Efavirenz (TLE) or Abacavir + Lamivudine.

  • Polymorphism & Stability: Lamivudine exists in different polymorphic forms (Form I and Form II). At our WHO-GMP facility, we strictly monitor the crystalline form to ensure consistent dissolution and shelf life.

  • Stability for Tropical Export: We utilize high-density polyethylene (HDPE) bottles with desiccants or Alu-Alu blister packaging to ensure a 36-month shelf life, which is critical for long-term supply chains in Zone IVb regions (Sub-Saharan Africa and Southeast Asia).

  • B2B & Public Health Tenders: This is a staple for the Global Fund and PEPFAR tenders. Our Mumbai-based facility provides the necessary eCTD Dossiers and stability data to participate in these large-scale institutional supplies.

Lamivudine Tablets

Add to cart